Based on these premises, we aimed to discover whether PARP1 co-regulates BRG1–EP300-dependent transcription, and if PARP1 can be considered an active component of such multiprotein complexes in the studied breast cancer cell lines. The gene discussed is EP300; the disease is breast carcinoma.